The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

Also called NCT06224296

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Shanghai Cell Therapy Group Co.,Ltd (from the registry)
Registry
  • NCT NCT06224296
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06224296. Allocation not applicable; no masking; primary purpose prevention. Start 2024-03-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
Condition
Sub-healthy
Condition
Hyperlipidemia
Condition
Toxic Metal Ions Accumulation
Intervention (Device)
DFPP
Intervention (Device)
DFPP
Intervention (Device)
DFPP
Lead sponsor
Shanghai Cell Therapy Group Co.,Ltd (class: industry)
Collaborator
Shanghai Mengchao Cancer Hospital (class: other)

Record details

Record id
cardio:ct-nct06224296
Content hash
3d77120f6b95519534e0223b25ba9bdaf8a7f6fbbbd7d2007947027553f731cf